Cargando…
ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) has single-digit 5-year survival rates at <7%. There is a dire need to improve pre-malignant detection methods and identify new therapeutic targets for abrogating PDAC progression. To this end, we mined our previously published pseudopodium-enriched (PDE) p...
Autores principales: | Gharibi, Armen, La Kim, Sa, Molnar, Justin, Brambilla, Daniel, Adamian, Yvess, Hoover, Malachia, Hong, Julie, Lin, Joy, Wolfenden, Laurelin, Kelber, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577248/ https://www.ncbi.nlm.nih.gov/pubmed/28855593 http://dx.doi.org/10.1038/s41598-017-09946-z |
Ejemplares similares
-
A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts
por: Hoover, Malachia, et al.
Publicado: (2016) -
Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives
por: Runa, Farhana, et al.
Publicado: (2016) -
PEAK1 Acts as a Molecular Switch to Regulate Context-Dependent TGFβ Responses in Breast Cancer
por: Agajanian, Megan, et al.
Publicado: (2015) -
Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor Resistance
por: Geller, Cameron, et al.
Publicado: (2023) -
Expression and Prognostic Analyses of ITGA3, ITGA5, and ITGA6 in Head and Neck Squamous Cell Carcinoma
por: Feng, Chen, et al.
Publicado: (2020)